scholarly journals Fluorescence-Guided Surgery for Hepatoblastoma with Indocyanine Green

Cancers ◽  
2019 ◽  
Vol 11 (8) ◽  
pp. 1215 ◽  
Author(s):  
Yohei Yamada ◽  
Michinobu Ohno ◽  
Akihiro Fujino ◽  
Yutaka Kanamori ◽  
Rie Irie ◽  
...  

Fluorescence-guided surgery with indocyanine green (ICG) for malignant hepatic tumors has been gaining more attention with technical advancements. Since hepatoblastomas (HBs) possess similar features to hepatocellular carcinoma, fluorescence-guided surgery can be used for HBs, as aggressive surgical resection, even for distant metastases of HBs, often contributes positively to R0 (complete) resection and subsequent patient survival. Despite a few caveats, fluorescence-guided surgery allows for the more sensitive identification of lesions that may go undetected by conventional imaging or be invisible macroscopically. This leads to precise resection of distant metastatic tumors as well as primary liver tumors.

2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Ruizhen Jia ◽  
Han Xu ◽  
Chenlu Wang ◽  
Lichao Su ◽  
Jinpeng Jing ◽  
...  

AbstractAccurate diagnosis and effective treatment of primary liver tumors are of great significance, and optical imaging has been widely employed in clinical imaging-guided surgery for liver tumors. The second near-infrared window (NIR-II) emissive AIEgen photosensitizers have attracted a lot of attention with higher-resolution bioimaging and deeper penetration. NIR-II aggregation-induced emission-based luminogen (AIEgen) photosensitizers have better phototherapeutic effects and accuracy of the image-guided surgery/phototherapy. Herein, an NIR-II AIEgen phototheranostic dot was proposed for NIR-II imaging-guided resection surgery and phototherapy for orthotopic hepatic tumors. Compared with indocyanine green (ICG), the AIEgen dots showed bright and sharp NIR-II emission at 1250 nm, which extended to 1600 nm with high photostability. Moreover, the AIEgen dots efficiently generated reactive oxygen species (ROS) for photodynamic therapy. Investigations of orthotopic liver tumors in vitro and in vivo demonstrated that AIEgen dots could be employed both for imaging-guided tumor surgery of early-stage tumors and for ‘downstaging’ intention to reduce the size. Moreover, the therapeutic strategy induced complete inhibition of orthotopic tumors without recurrence and with few side effects. Graphical Abstract


HPB ◽  
2021 ◽  
Vol 23 ◽  
pp. S821
Author(s):  
M. Moratal ◽  
M. Martínez-López ◽  
C. Gómez Gavara ◽  
B. Benet ◽  
C. Dopazo ◽  
...  

2020 ◽  
Vol 25 (05) ◽  
pp. 1
Author(s):  
Alberto J. Ruiz ◽  
Mindy Wu ◽  
Ethan Philip M. LaRochelle ◽  
Dimitris Gorpas ◽  
Vasilis Ntziachristos ◽  
...  

2018 ◽  
Vol 118 (2) ◽  
pp. 324-331 ◽  
Author(s):  
Yuichi Nakaseko ◽  
Takeaki Ishizawa ◽  
Akio Saiura

Sign in / Sign up

Export Citation Format

Share Document